Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin’s disease

By Hummel Margit  

Annals of Hematology, Vol. 83, Iss. 7, 2004-07 ,pp. : 441-443

Springer Publishing Company

Access to resources Recommend Favorite

What is the Best Option to Cure Patients with Resistant/Relapsing Hodgkin’s Disease?

By  

Current Stem Cell Research & Therapy, Vol. 1, Iss. 3, 2006-09 ,pp. : 419-424

Bentham Science Publishers

Access to resources Recommend Favorite

FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin’s lymphoma and Hodgkin’s disease

By Querellou Solène   Valette Frédéric   Bodet-Milin Caroline   Oudoux Aurore   Carlier Thomas   Harousseau Jean-Luc   Chatal Jean-François   Couturier Olivier  

Annals of Hematology, Vol. 85, Iss. 11, 2006-11 ,pp. : 759-767

Springer Publishing Company

Access to resources Recommend Favorite

TiA1 in advanced-stage classical Hodgkin’s lymphoma: no prognostic impact for positive tumour cells or number of cytotoxic cells

By Camilleri-Broët Sophie  

Virchows Archiv, Vol. 445, Iss. 4, 2004-10 ,pp. : 344-346

Springer Publishing Company

Access to resources Recommend Favorite

Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin’s disease

By Brosteanu O.  

Annals of Hematology, Vol. 83, Iss. 3, 2004-03 ,pp. : 176-182

Springer Publishing Company

Access to resources Recommend Favorite